BUY IPCA Laboratories Limited — Siddharth Rai Mangala
bySiddharth Rai MangalaHorizon: NA (inferred Swing (≤2wk))25 Sept 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·21 Sept · 4d ago
Ipca Labs Rallies 50% on Q1 Growth; Analysts Flag Valuation Limits
NewsGoogle News·16 Sept · 1w ago
3 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·18 Aug · 1mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on IPCA Laboratories
- BUY — Prabhudas Lilladher6 Nov 2026 · ~1 year · target ₹2,200 · Active
- BUY — Amit Seth27 Oct 2026 · ~2 weeks · target ₹2,060 · SL hit
- BUY — Nilesh Jain, Centrum Broking27 Oct 2026 · ~2 weeks · target ₹2,040 · SL hit
- BUY — IDBI Capital27 Oct 2026 · ~2 weeks · target ₹2,066 · SL hit
- BUY — Sahi Research26 Oct 2026 · ~2 weeks · target ₹2,045 · SL hit
More from Siddharth Rai Mangala
- BUY Anand Rathi Wealth13 Nov 2026 · ~1 year · target ₹2,440 · Active
- BUY FSN E-Commerce Ventures13 Nov 2026 · ~2 weeks · target ₹385 · Active
- BUY Premier Energies13 Nov 2026 · ~1 year · target ₹930 · Active
- BUY Max Healthcare Institute13 Nov 2026 · ~2 weeks · target ₹975 · Active
- BUY V2 Retail12 Nov 2026 · ~1 year · target ₹280 · Active

